ArticleDrug delivery and translational research2014

Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease.

Rajkumar Malayandi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.